Core Insights - Plexus Corp. released its fiscal 2024 Sustainability Report, emphasizing its commitment to sustainability and responsible innovation as integral to its values [1][2] - The report highlights significant achievements in enhancing employee growth, strengthening partnerships, and reducing environmental impact [2][6] Sustainability Achievements - Achieved a 6.4% absolute reduction in Scope 1 & 2 combined emissions compared to the fiscal 2023 baseline [6] - Delivered a 13.7% global reduction in waste to landfill intensity year-over-year [6] - Contributed over $1 million globally through the Plexus Community Foundation [6] - Recorded over 20,000 paid volunteer hours in local communities, marking a 10.7% increase year-over-year [6] - Assessed over 50% of its global supply chain spend based on sustainability criteria [6] Company Overview - Plexus has been partnering with companies since 1979 to create products that contribute to a better world, employing over 20,000 individuals [4] - The company specializes in providing Design and Development, Supply Chain Solutions, New Product Introduction, Manufacturing, and Sustaining Services [4]

Core Viewpoint - Plexus (PLXS) shares have increased by approximately 4.1% since the last earnings report, underperforming the S&P 500, raising questions about the sustainability of this trend leading up to the next earnings release [1] Group 1: Earnings Report and Market Reaction - Recent estimates for Plexus have trended downward over the past month, indicating a negative sentiment among analysts [2] - The stock has a strong Growth Score of A but is rated F for Momentum, while it holds an A for Value, placing it in the top quintile for this investment strategy [3] Group 2: Outlook and Future Expectations - The downward trend in estimates suggests a broader negative shift, with Plexus currently holding a Zacks Rank of 3 (Hold), indicating expectations for an in-line return in the coming months [4]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________________________________________________________________ FORM 10-Q ____________________________________________________________________________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2025 ...

FISCAL SECOND QUARTER 2025 HIGHLIGHTS April 23, 2025 PLEXUS CONFIDENTIAL SAFE HARBOR AND FAIR DISCLOSURE STATEMENT Some of the statements made and information provided during our call as well as information included in the supporting materials will be forward looking statements, including, without limitation, those regarding revenue, gross margin, selling and administrative expense, operating margin, other income and expense, taxes, cash cycle, capital allocation and future business outlook. Forward-looking ...

Plexus (PLXS) Q2 2025 Earnings Call April 25, 2025 12:48 AM ET Company Participants Shawn Harrison - Vice President - IRTodd Kelsey - President & CEOOliver Mihm - Executive VP & COOPatrick Jermain - EVP & CFOMelissa Fairbanks - Vice PresidentSteven Fox - Founder & CEORuben Roy - Managing Director - Equity ResearchChris Grenga - Equity Research AssociateSteve Barger - Managing Director - Equity Research Conference Call Participants David Williams - Equity Research AnalystAnja Soderstrom - Senior Equity Resea ...

Financial Data and Key Metrics Changes - Revenue for the fiscal second quarter was $980 million, meeting guidance [11] - Non-GAAP operating margin was 5.7%, at the high end of guidance [12] - Non-GAAP EPS was $1.66, exceeding guidance due to strong operating margin performance and favorable tax rate [13] - Free cash flow generated was $16.5 million, significantly better than expectations [13] Business Line Data and Key Metrics Changes - Aerospace and defense sector revenue increased 8% sequentially, with healthy wins of $27 million [27][28] - Healthcare life sciences sector revenue was up 10% sequentially, with wins of $118 million, including the largest-ever award for sustaining services [32][33] - Industrial sector revenue decreased 10% sequentially, with wins of $60 million [36][38] - Semi cap sector showed robust growth, with high teens growth expected for the fiscal year [111] Market Data and Key Metrics Changes - Incremental strengthening in healthcare customer outlooks offset modest reductions in other markets [12] - Signs of inventory corrections peaking in the broader industrial market [23] - Demand in aerospace and defense is being offset by reduced near-term demand in the aerospace subsector [30] Company Strategy and Development Direction - Company is strategically investing in talent, technology, and facilities to navigate current market complexities [9] - Continued focus on sustainability and innovation as core values [16] - Anticipates $100 million of free cash flow for fiscal 2025, aiming for meaningful EPS growth [10][22] Management's Comments on Operating Environment and Future Outlook - Management acknowledges macroeconomic uncertainty but remains optimistic about achieving meaningful EPS growth in fiscal 2025 [22][137] - Customers are currently taking a wait-and-see approach regarding tariffs, with no immediate impact on demand noted [66] - Company is well-positioned to adjust to customer needs and market conditions [64] Other Important Information - Company recognized as Manufacturer of the Year Mega Category by Wisconsin Manufacturers and Commerce [17] - New facility in Malaysia expected to open this summer, enhancing capacity [68] Q&A Session Summary Question: Impact of tariffs on operations - Management indicated that customers are taking a wait-and-see approach regarding tariffs, with no immediate demand degradation observed [62][66] Question: Capacity and new facilities - Current capacity is sufficient across regions, with new facility in Malaysia expected to enhance operations [68] Question: Cash cycle days target - Management aims for cash cycle days to improve to mid to low sixties, with each day of reduction freeing up $10 million in cash flow [75][76] Question: Dynamics behind outsourcing in aerospace and defense - Increased openness to outsourcing observed among customers due to changes in demand relative to capacity [80][82] Question: Details on healthcare sustainable services program - Program involves single-use capital equipment, with potential for significant ramp-up over two to three quarters [86] Question: Industrial market demand signals - Inventory corrections appear to have peaked, leading to stronger demand signals from industrial customers [98] Question: Engineering wins diversification - Engineering wins have diversified across multiple sectors, indicating strong future growth potential [118] Question: Currency hedging strategy - Company is actively hedging against currency volatility to mitigate potential impacts on P&L [124]

Core Viewpoint - Plexus Corp reported strong adjusted earnings per share (EPS) for the second quarter of fiscal 2025, exceeding expectations, but revenues slightly missed estimates due to mixed performance across sectors [1][2]. Financial Performance - Adjusted EPS for Q2 fiscal 2025 was $1.66, up from $1.19 in the same quarter last year, surpassing the Zacks Consensus Estimate of $1.54 [1]. - Revenues reached $980.2 million, a 1.4% year-over-year increase, but fell short of the Zacks Consensus Estimate of $980.5 million [2]. - Gross profit on a GAAP basis increased 11% year over year to $97.8 million, with a gross margin of 10%, up from 9.1% [6]. Revenue Breakdown - Healthcare/Life Sciences revenues rose 8.4% year over year to $411 million, contributing 42% to total revenues [5]. - Industrial sector revenues decreased 5% year over year to $397 million, accounting for 40% of total revenues [4]. - Revenues from Asia-Pacific increased by 12.5% to $587 million, while EMEA sales declined by 32% [2]. Operational Highlights - Plexus secured 42 manufacturing program wins in the quarter, expected to generate $205 million in annualized revenues once fully ramped [3]. - Selling and administrative expenses rose 3% year over year to $49 million, while adjusted operating margin expanded by 80 basis points to 5.7% [8]. Balance Sheet and Cash Flow - As of March 29, 2025, cash and cash equivalents were $310.5 million, down from $317.2 million as of December 28, 2024 [9]. - Free cash flow for the quarter was reported at $16.5 million [9]. Share Repurchase and Future Outlook - The company repurchased $12.2 million of shares at an average price of $141.18, with $25 million remaining under its $50 million buyback authorization [10]. - For Q3 fiscal 2025, revenues are anticipated to be between $1 billion and $1.04 billion, with non-GAAP EPS expected in the range of $1.65-$1.80 [11].

Core Insights - Plexus reported revenue of $980.17 million for the quarter ended March 2025, reflecting a year-over-year increase of 1.4% [1] - The company's EPS was $1.66, significantly higher than the $0.94 reported in the same quarter last year, indicating strong earnings growth [1] - The revenue slightly missed the Zacks Consensus Estimate of $980.47 million by 0.03%, while the EPS exceeded the consensus estimate of $1.54 by 7.79% [1] Revenue Performance by Sector - Healthcare/Life Sciences sector generated revenue of $411 million, surpassing the average estimate of $407.10 million, with a year-over-year increase of 8.4% [4] - Aerospace/Defense sector reported revenue of $172 million, slightly below the estimated $174.10 million, marking a year-over-year increase of 1.2% [4] - Industrial sector revenue was $397 million, falling short of the estimated $399.55 million, representing a year-over-year decrease of 5% [4] Stock Performance - Plexus shares have returned -6.1% over the past month, compared to a -6.6% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Group 1 - Plexus reported quarterly earnings of $1.66 per share, exceeding the Zacks Consensus Estimate of $1.54 per share, and showing a significant increase from $0.94 per share a year ago, representing an earnings surprise of 7.79% [1] - The company posted revenues of $980.17 million for the quarter ended March 2025, slightly missing the Zacks Consensus Estimate by 0.03%, but showing growth from $966.9 million year-over-year [2] - Plexus has surpassed consensus EPS estimates in all four of the last quarters, but has only topped revenue estimates once during the same period [2] Group 2 - The stock has underperformed, losing about 20.7% since the beginning of the year, compared to a decline of 10.1% for the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $1.74 on revenues of $1.03 billion, and for the current fiscal year, it is $6.90 on revenues of $4.08 billion [7] - The Zacks Industry Rank for Electronics - Manufacturing Services is in the top 14% of over 250 Zacks industries, indicating a favorable outlook for the sector [8] Group 3 - The estimate revisions trend for Plexus is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6] - Celestica, another company in the same industry, is expected to report quarterly earnings of $1.11 per share, reflecting a year-over-year increase of 29.1%, with revenues projected at $2.55 billion, up 15.3% from the previous year [9][10]

Financial Performance - Plexus reported fiscal second quarter 2025 revenue of $980 million, with a GAAP operating margin of 5.0% and diluted EPS of $1.41[5] - Non-GAAP operating margin for the second quarter was 5.7%, and adjusted diluted EPS was $1.66, excluding $0.25 of stock-based compensation expense[5] - Net sales for the three months ended March 29, 2025, were $980.17 million, a 1.3% increase from $966.90 million for the same period in 2024[20] - Gross profit for the three months ended March 29, 2025, was $97.75 million, compared to $88.06 million for the same period in 2024, reflecting a 10.5% increase[20] - Operating income for the three months ended March 29, 2025, was $48.79 million, up 65.5% from $29.47 million in the same period last year[20] - Net income for the three months ended March 29, 2025, was $39.07 million, significantly higher than $16.24 million for the same period in 2024, representing a 140.5% increase[20] - Basic earnings per share for the three months ended March 29, 2025, were $1.44, compared to $0.59 for the same period in 2024, marking a 144.1% increase[20] - Adjusted operating income for the six months ended March 29, 2025, was $100.33 million, compared to $51.54 million for the same period in 2024[29] - Adjusted diluted earnings per share for the six months ended March 29, 2025, were $3.39, up from $2.42 for the same period in 2024, reflecting a 40.2% increase[24] Guidance and Future Outlook - The company initiated fiscal third quarter 2025 revenue guidance of $1.00 billion to $1.04 billion, with GAAP diluted EPS guidance of $1.40 to $1.55[5] Cash Flow and Capital Management - Free cash flow for the second quarter was $16.5 million, contributing to year-to-date free cash flow of $43.6 million[6] - The cash cycle for the second quarter was 68 days, consistent with the first quarter and showing improvement in inventory management[7] - Return on invested capital (ROIC) for the second quarter was 13.7%, exceeding the weighted average cost of capital by 480 basis points[12] - Return on invested capital (ROIC) for the six months ended March 29, 2025, was 13.7%, compared to 9.9% for the same period in 2024[29] Shareholder Actions - The company repurchased $12.2 million of its shares at an average price of $141.18 per share, with $25 million remaining under the share repurchase authorization[6] Revenue Composition - Revenue from the Aerospace/Defense sector was $172 million, accounting for 18% of total revenue, while Healthcare/Life Sciences contributed $411 million, or 42%[10] - Top 10 customers comprised 51% of revenue during the second quarter, an increase of 3 percentage points from the same quarter in the previous year[9] Balance Sheet Highlights - Total current assets decreased to $2,396.31 million as of March 29, 2025, from $2,477.15 million as of September 28, 2024[22] - Total liabilities decreased to $1,734.07 million as of March 29, 2025, from $1,828.99 million as of September 28, 2024[22]